The suits were consolidated and brought to the U.S. District Court in Western Texas. The settlement would settle all claims arising from the purchase or sale of ArthroCare securities between Dec. 11, 2007 and Feb. 18, 2009.
If the $74 million settlement is approved, the plaintiffs’ counsel will apply for an award of attorney’s fees and reimbursement of expenses from the settlement fund.
Related Articles on Orthopedic Device Companies:
Global Orthopedic Implant Market to Reach $46.5B by 2017
InVivo Therapeutics Reports $3M Net Income in 3Q
Alphatec Spine Names Frances Harrison to Vice President Position
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.